WHO ICTRP trial
A clinical trial to evaluate the efficacy and safety of traditional Chinese…
ChiCTR-OOC-16009861 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-OOC-16009861 |
|---|---|
| Public title | A clinical trial to evaluate the efficacy and safety of traditional Chinese medicine preventing relapse and metastasis of triple-negative breast cancer breast cancer |
| Scientific title | A clinical trial to evaluate the efficacy and safety of traditional Chinese medicine preventing relapse and metastasis of triple-negative breast cancer breast cancer |
| Primary sponsor | Longhua Hospital Shanghai University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | triple negative breast cancer |
| Interventions | Traditional Chinese medicine (TCM) exposed group:Western medicine standard treatment with traditional Chinese medicine therapy;Traditional Chinese medicine (TCM) nonexposed group:Western medicine standard treatment without Traditional… |
| Registration date | Nov 14, 2016 |
| Target size | Traditional Chinese medicine (TCM) exposed group:310;Traditional Chinese… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: